Impact Patient Care with a Research Grant
The Patient Directed Investigation Grant exists to support translational studies that have the potential to benefit patients directly. Such studies may concern medical dermatology, dermatologic surgery, procedural dermatology, pediatric dermatology, or other aspects of the specialty that impact patient care. Funding is intended to enhance the career development of patient-oriented clinical investigators in the early stages of their career development.
Know Before You Apply
All Foundation-funded research must be conducted in the U.S. under the sponsorship of a department/division of dermatology that is ACGME-approved for training in dermatology. Applicants must meet the DF’s general eligibility requirements, in addition to award-specific requirements presented on or before the time of funding. Minority applicants are encouraged to apply.
The DF encourages applications concerning health issues impacting minority groups, including, but not limited to, racial minorities, sexual¬ gender/LGBTQ minorities, and underserved/disadvantaged populations.
Patient Directed Investigation Grant FAQs
Applications will be judged by the Medical and Scientific Committee’s panel of recognized experts in applied medical, surgical, procedural, and pediatric dermatology. It is the expectation that the recipients of this award will be the future clinical leaders in dermatology, helping to shape the future of the specialty. Recipients may apply for a second year of funding on a competitive basis.
Am I eligble?
If you meet all of the requirements below, you may be eligible to apply for the Patient Directed Investigation Grant.
If you meet the requirements below, you may be eligible to apply for a Patient Directed Investigation Grant.
- M.D.; M.D., Ph.D.; Ph.D.; or D.O. degree
- Proposed research focuses on women’s health issue
- Junior investigator in the early stages of academic career
- Demonstrates a strong commitment to skin research
- Project not funded from other sources
- NOT available to residents unless in a research year of a 4-year program defined by no more than 20% of time devoted to clinical responsibilities
How do I apply for the Patient Directed Investigation Grant?
The PDF application instructions provide essential information potential applicants need to know to evaluate the various award opportunities and develop a successful application and research proposal. Interested individuals are strongly encouraged to read sections II and III before beginning any paperwork.
Application deadline: October 15, 2021
Featured Award Recipient
Cell Signaling Changes Induced by Surgical Debulking May Improve Response to Smoothened Inhibitor Therapy
Smoothened (SMO) inhibitors, such as vismodegib, are effective treatments for locally advanced basal cell carcinomas (BCCs). However, recurrences are frequent upon treatment discontinuation. Our clinical observations suggest long-term remission for patients undergoing surgical debulking of exophytic BCCs prior to SMO inhibitor therapy. This study intends to correlate key oncogenic signaling pathways induced by surgical debulking with improved patient outcomes with SMO inhibitors.
Charlene Lam, M.D., MPH
Pennsylvania State University
Patient Directed Investigation Grant
Award Recipients | Patient Directed Investigation Grant
Charlene Lam, M.D.
Pennsylvania State University
Cell Signaling Changes Induced by Surgical Debulk May Improve Response to Smoothened Inhibitor Therapy